-
2101“…A 49-year-old woman was diagnosed with stage IVa pancreatic cancer. She underwent surgery, and subsequent adjuvant chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2102“…Neutrophil extracellular traps (NETs), are associated with cancer development and hypercoagulability in various cancers, including pancreatic cancer. On the other hand, pancreatic cancer development is associated with increased NETs formation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2103por Li, Jiajia, Peng, Liyao, Chen, Qun, Ye, Ziping, Zhao, Tiantian, Hou, Sicong, Gu, Jianguo, Hang, Qinglei“…SIMPLE SUMMARY: Pancreatic cancer (PC) is a highly aggressive malignant tumor with an extremely poor prognosis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2104por Maietta, Immacolata, Martínez-Pérez, Amparo, Álvarez, Rosana, De Lera, Ángel R., González-Fernández, África, Simón-Vázquez, RosanaEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2105por Kerk, Samuel A, Lin, Lin, Myers, Amy L, Sutton, Damien J, Andren, Anthony, Sajjakulnukit, Peter, Zhang, Li, Zhang, Yaqing, Jiménez, Jennifer A, Nelson, Barbara S, Chen, Brandon, Robinson, Anthony, Thurston, Galloway, Kemp, Samantha B, Steele, Nina G, Hoffman, Megan T, Wen, Hui-Ju, Long, Daniel, Ackenhusen, Sarah E, Ramos, Johanna, Gao, Xiaohua, Nwosu, Zeribe C, Galban, Stefanie, Halbrook, Christopher J, Lombard, David B, Piwnica-Worms, David R, Ying, Haoqiang, Pasca di Magliano, Marina, Crawford, Howard C, Shah, Yatrik M, Lyssiotis, Costas AEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2106
-
2107por Hu, Xiaoge, Lei, Xiangxiang, Guo, Jinhui, Fu, Wen, Sun, Wen, Lu, Qiliang, Su, Wei, Xu, Qiuran, Tu, Kangsheng“…Pancreatic cancer (PC) is one of the most common malignant cancers, ranking the seventh highest causes of cancer-related deaths globally. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2108por Zeng, Siyuan, Lan, Bin, Ren, Xiaofan, Zhang, Shuman, Schreyer, Daniel, Eckstein, Markus, Yang, Hai, Britzen-Laurent, Nathalie, Dahl, Andreas, Mukhopadhyay, Debabrata, Chang, David, Kutschick, Isabella, Pfeffer, Susanne, Bailey, Peter, Biankin, Andrew, Grützmann, Robert, Pilarsky, Christian“…CONCLUSIONS: Our findings support the application of CRISPR-Cas9 screening in identifying novel therapeutic targets and suggest new strategies for overcoming chemoresistance in pancreatic cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02443-w.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2109“…This review focuses on the recent progress in precision medicine for advanced unresectable hepatobiliary and pancreatic cancers. We highlight therapies that target several regulators of cancer cell growth and tumor-agnostic therapies that effectively treat biliary and pancreatic cancers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2110por Nishimoto, Arata“…Pancreatic cancer is highly aggressive and lethal. Due to the lack of effective methods for detecting the disease at an early stage, pancreatic cancer is frequently diagnosed late. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2111por Yin, Hua, Zhang, Feixiong, Yang, Xiaoli, Meng, Xiangkun, Miao, Yu, Noor Hussain, Muhammad Saad, Yang, Li, Li, Zhaoshen“…CONCLUSION: The research related to AI in pancreatic cancer is still in the initial stage. Currently, AI is widely studied in biology, diagnosis, treatment, risk assessment, and EUS of pancreatic cancer. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2112por Frigerio, Isabella, Malleo, Giuseppe, de Pastena, Matteo, Deiro, Giacomo, Surci, Niccolò, Scopelliti, Filippo, Esposito, Alessandro, Regi, Paolo, Giardino, Alessandro, Allegrini, Valentina, Bassi, Claudio, Girelli, Roberto, Salvia, Roberto, Butturini, GiovanniEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2113“…Conclusion: We found a cohort of CDRG and CIC in patients with pancreatic cancer. The combined prognostic model provided new insights into the prognosis and treatment of pancreatic cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2114por Brouwer, Thomas, Ijsselsteijn, Marieke, Oosting, Jan, Ruano, Dina, van der Ploeg, Manon, Dijk, Frederike, Bonsing, Bert, Fariña, Arantza, Morreau, Hans, Vahrmeijer, Alexander, de Miranda, Noel“…SIMPLE SUMMARY: Pancreatic cancer is one of the most lethal cancer types and its high refractoriness to therapies, including immunotherapy, has often been associated with the predominantly immune suppressive tumor microenvironment that characterizes pancreatic tumors. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2115
-
2116por Ji, Hongchen, Zhang, Qiong, Wang, Xiang-Xu, Li, Junjie, Wang, Xiaowen, Pan, Wei, Zhang, Zhuochao, Ma, Ben, Zhang, Hong-Mei“…PURPOSE: Pancreatic cancer is one of the deadliest cancers worldwide. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2117“…Until now, the potential function and pathway of MSMO1 in the development of pancreatic cancer (PC) has not been explored yet, to our knowledge. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2118“…PALB2 mutation may also increase the risk of pancreatic cancer. New guidelines for PALB2 mutation in breast cancer advise pancreatic cancer screening, which includes M.R.I.s of the pancreas as well as endoscopic ultrasonography, for women who have a family history of pancreatic cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2119por McNeil, Logan R., Blair, Alex B., Krell, Robert W., Zhang, Chunmeng, Ejaz, Aslam, Groot, Vincent P., Gemenetzis, Georgios, Padussis, James C., Falconi, Massimo, Wolfgang, Christopher L., Weiss, Matthew J., Are, Chandrakanth, He, Jin, Reames, Bradley N.“…BACKGROUND: Recent literature suggests wide variations exist in the international management of locally advanced pancreatic cancer. This study sought to evaluate how geography contributes to variations in management of locally advanced pancreatic cancer. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2120por Chen, Sai, Ren, Hefei, Zhang, Xiaomin, Chang, Liu, Wang, Zhenhua, Wu, Hongkun, Zhang, Jiafeng, Ren, Jigang, Zhou, Lin“…RESULTS: Among classical m6A regulators, while METTL3, METTL14, WTAP, FTO, YTHDF2, IGF2BP1–3, hnRNPC, and NKAP are upregulated in pancreatic cancer, METTL16 and ALKBH5 are downregulated in pancreatic cancer. m6A modification has been investigated in pancreatic cancer therapy. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto